Ludwig AignerÂ
Director
Institute for Molecular Regenerative MedicineÂ
Paracelsus Private Medical University of Salzburg
Austria
Biography
Director of the Institute of Molecular Regenerative Medicine, Spinal Cord & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (2013). Endowed Professorship of the State of Salzburg, Director of the Institute of Molecular Regenerative Medicine, Paracelsus Medical University (2008 -2013). Associate Professor for Clinical Neuroscience; Head of Research, Department of Neurology, University of Regensburg. University of Regensburg, Germany (2006 -2008). Habilitation in Experimental Neurology, University of Regensburg, Germany (2005). Appointment as Privatdozent at University Regensburg, Germany ( 2005). Volkswagen-Foundation young investigator group 'molecular and cell biology of adult neural stem cells', University Regensburg, Germany (1999 -2006).
Research Interest
Spinal Cord & Tissue Regeneration
Publications
-
Adamczak J, Aswendt M, Kreutzer C, Rotheneichner P, Riou A, Selt M, Beyrau A, Uhlenküken U, Diedenhofen M, Nelles M, Aigner L. Neurogenesis upregulation on the healthy hemisphere after stroke enhances compensation for age-dependent decrease of basal neurogenesis. Neurobiology of disease. 2017 Mar 31;99:47-57.
-
Rotheneichner P, Romanelli P, Bieler L, Pagitsch S, Zaunmair P, Kreutzer C, König R, Marschallinger J, Aigner L, Couillard-Després S. Tamoxifen activation of Cre-Recombinase has no persisting effects on adult neurogenesis or learning and anxiety. Frontiers in neuroscience. 2017;11.
-
Kugler M, Schlecht A, Fuchshofer R, Schmitt SI, Kleiter I, Aigner L, Tamm ER, Braunger BM. SMAD7 deficiency stimulates Müller progenitor cell proliferation during the development of the mammalian retina. Histochemistry and Cell Biology. 2017 Mar 3:1-2.
